Rizwan Romee is an expert in the field of Hematology. He attended Government Medical College Srinagar. He has 6 awards "ASCO Career Development Award (faculty)", "ASH Scholar Award (faculty-clinical)", "ICTS Translational Research Award", "Barnes Jewish Hospital Foundation Team Science Award", "Siteman Cancer Center Research & Development Award" and "CMS Meaningful Use Stage 1 Certification". Rizwan Romee, MD has written publications. He has 17 publications published with PubMed. The lastest publication is: 'Peri-transplant serum albumin decline predicts subsequent severe acute graft-versus-host disease following mucotoxic myeloablative conditioning.' He accepts Medicare.
NPI NUMBER | 1942493101 | |
NPPES Provider LastName | ROMEE | |
NPPES Provider FirstName | RIZWAN | |
NPPES Provider ZIPCode | 631101032 | |
NPPES Provider State | MO | |
Specialty Description | Medical Oncology | |
Total Claim Count | 31.0 | |
Distinct Opioid Count | 0.0 | |
Opioid Claim Count | 0.0 | |
Percent Opioid Claims | 0.0 |
National Provider Identifier [NPI] | 1942493101 |
Last Name Of The Provider | ROMEE |
First Name Of The Provider | RIZWAN |
View All |
![]() |
Dr. Armin Ghobadi, MD
![]() |
![]() |
Dr. Leonard A. White Jr., MD
![]() |
![]() |
Dr. Michael J. Naughton, MD |
![]() |
Dr. Gregg E. Davies, MD |
![]() |
Dr. James M. Epstein, MD |
![]() |
Dr. Ravi Vij, MD
![]() ![]() |